Free Trial
OTCMKTS:INBP

Integrated BioPharma (INBP) Stock Price, News & Analysis

Integrated BioPharma logo
$0.31 -0.01 (-2.79%)
As of 11:37 AM Eastern

About Integrated BioPharma Stock (OTCMKTS:INBP)

Key Stats

Today's Range
$0.30
$0.31
50-Day Range
$0.26
$0.36
52-Week Range
$0.16
$0.42
Volume
9,400 shs
Average Volume
20,922 shs
Market Capitalization
$9.60 million
P/E Ratio
7.75
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive INBP Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Integrated BioPharma and its competitors with MarketBeat's FREE daily newsletter.

INBP Stock News Headlines

INBP Integrated BioPharma, Inc.
The End of Elon Musk…?
The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, and he's been proven right time and time again. And now, while the media focuses on Tesla's "demise," he's uncovered an AI breakthrough that's about to make Elon's doubters eat their words yet again. According to his research, if you listen to the media and miss out on Elon's newest breakthrough, it's going to cost you the fortune of a lifetime.
Integrated Biopharma Inc (INBP)
Integrated BioPharma, Inc. (INBP)
See More Headlines

INBP Stock Analysis - Frequently Asked Questions

Integrated BioPharma's stock was trading at $0.3297 on January 1st, 2025. Since then, INBP shares have decreased by 6.0% and is now trading at $0.31.

Integrated BioPharma Inc. (OTCMKTS:INBP) issued its quarterly earnings data on Wednesday, May, 14th. The company reported $0.02 earnings per share (EPS) for the quarter. The business earned $13.95 million during the quarter. Integrated BioPharma had a trailing twelve-month return on equity of 6.36% and a net margin of 2.37%.

Shares of INBP stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Integrated BioPharma investors own include GSK (GSK), Invitae (NVTA), Exxon Mobil (XOM), Autodesk (ADSK), Adaptive Biotechnologies (ADPT), Analog Devices (ADI) and Adaptimmune Therapeutics (ADAP).

Company Calendar

Last Earnings
5/14/2025
Today
7/18/2025
Next Earnings (Estimated)
9/18/2025
Fiscal Year End
6/30/2026

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Sector
Medical
Industry
MED - DRUGS
Sub-Industry
Pharmaceutical Products
Current Symbol
OTCMKTS:INBP
CIK
1016504
Employees
150
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
$0.04
Trailing P/E Ratio
7.75
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$110 thousand
Net Margins
2.37%
Pretax Margin
3.55%
Return on Equity
6.36%
Return on Assets
4.84%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
3.72
Quick Ratio
1.70

Sales & Book Value

Annual Sales
$50.32 million
Price / Sales
0.19
Cash Flow
$0.04 per share
Price / Cash Flow
7.11
Book Value
$0.64 per share
Price / Book
0.48

Miscellaneous

Outstanding Shares
30,980,000
Free Float
10,160,000
Market Cap
$9.60 million
Optionable
Not Optionable
Beta
0.81

Social Links

Analysts Agree—These Gold Picks Outshine the Rest Cover

Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.

Get This Free Report

This page (OTCMKTS:INBP) was last updated on 7/18/2025 by MarketBeat.com Staff
From Our Partners